The association between tricuspid regurgitation velocity and 5‐year survival in a North West London population of patients with sickle cell disease in the United Kingdom
暂无分享,去创建一个
J. Grapsa | P. Nihoyannopoulos | D. Dawson | F. Pinto | P. Bassett | L. Howard | S. Davies | J. Howard | J. Gibbs | K. Anie | S. Ghorashian | M. Layton | Gavin Cho | Annette Gilmore | A. Mohammed | Inês Zimbarra Cabrita | L. Desforges | Gaia Mahalingam
[1] J. Stockman,et al. A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease , 2013 .
[2] M. Gladwin,et al. Risk Factors for Death in 632 Patients with Sickle Cell Anemia in the United States and United Kingdom , 2012 .
[3] V. Salemi,et al. Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease , 2011, European Respiratory Journal.
[4] L. Savale,et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. , 2011, The New England journal of medicine.
[5] D. Spevack,et al. An Elevated Estimated Pulmonary Arterial Systolic Pressure, Whenever Measured, Is Associated with Excess Mortality in Adults with Sickle Cell Disease , 2011, Acta Haematologica.
[6] M. Gladwin,et al. Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective. , 2010, Chest.
[7] M. Telen,et al. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease , 2009, American journal of hematology.
[8] C. Quinn,et al. Improved survival of children and adolescents with sickle cell disease. , 2008, Blood.
[9] O. Bech-Hanssen,et al. Doppler echocardiography can provide a comprehensive assessment of right ventricular afterload. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[10] James B. Seward,et al. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. , 2008, Journal of the American College of Cardiology.
[11] A. Ashley-Koch,et al. Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes , 2008, American journal of hematology.
[12] A. Thompson,et al. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension , 2007, Haematologica.
[13] M. Cairo,et al. Pulmonary hypertension in sickle cell disease. , 2007, Clinical advances in hematology & oncology : H&O.
[14] F. Kirkham,et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. , 2007, Haematologica.
[15] Vandana Sachdev,et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. , 2007, American journal of respiratory and critical care medicine.
[16] F. Yalçin,et al. Pulmonary Hypertension in Sickle-Cell Disease: Comorbidities and Echocardiographic Findings , 2007, Acta Haematologica.
[17] C. Moore,et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study , 2006, British journal of haematology.
[18] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[19] A. Ashley-Koch,et al. Pulmonary Hypertension in SS, SC and Sβ Thalassemia: Prevalence, Associated Clinical Syndromes, and Mortality. , 2004 .
[20] K. Ataga,et al. Pulmonary hypertension in sickle cell disease. , 2004, The American journal of medicine.
[21] J. Gardin,et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[22] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[23] M. Gladwin,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[24] R. Ware,et al. Malignancy in patients with sickle cell disease , 2003, American journal of hematology.
[25] O. Castro,et al. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. , 2003, Blood.
[26] C. Klersy,et al. Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure. , 2002, American heart journal.
[27] C. Otto,et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] M. Hickman,et al. Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic‐specific rates , 1999, British journal of haematology.
[29] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.
[30] J. Niland,et al. Sickle Cell Chronic Lung Disease: Prior Morbidity and the Risk of Pulmonary Failure , 1988, Medicine.
[31] B. Angelsen,et al. Non-invasive estimation of pulmonary artery systolic pressure with Doppler ultrasound. , 1981, British heart journal.